IL159735A0 - Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity - Google Patents
Substituted amides, sulfonamides and ureas useful for inhibiting kinase activityInfo
- Publication number
- IL159735A0 IL159735A0 IL15973502A IL15973502A IL159735A0 IL 159735 A0 IL159735 A0 IL 159735A0 IL 15973502 A IL15973502 A IL 15973502A IL 15973502 A IL15973502 A IL 15973502A IL 159735 A0 IL159735 A0 IL 159735A0
- Authority
- IL
- Israel
- Prior art keywords
- sulfonamides
- kinase activity
- substituted amides
- inhibiting kinase
- ureas useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30402001P | 2001-07-09 | 2001-07-09 | |
GBGB0127615.3A GB0127615D0 (en) | 2001-07-09 | 2001-11-19 | Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
PCT/US2002/021525 WO2003006444A2 (en) | 2001-07-09 | 2002-07-09 | Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
Publications (1)
Publication Number | Publication Date |
---|---|
IL159735A0 true IL159735A0 (en) | 2004-06-20 |
Family
ID=26246780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15973502A IL159735A0 (en) | 2001-07-09 | 2002-07-09 | Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1423373B1 (xx) |
AT (1) | ATE307125T1 (xx) |
AU (1) | AU2002320330B2 (xx) |
CA (1) | CA2453169A1 (xx) |
DE (1) | DE60206782T2 (xx) |
ES (1) | ES2247357T3 (xx) |
IL (1) | IL159735A0 (xx) |
MX (1) | MXPA04000040A (xx) |
WO (1) | WO2003006444A2 (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030130209A1 (en) * | 1999-12-22 | 2003-07-10 | Cheresh David A. | Method of treatment of myocardial infarction |
US7427683B2 (en) * | 2003-04-25 | 2008-09-23 | Ortho-Mcneil Pharmaceutical, Inc. | c-fms kinase inhibitors |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9903762D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
-
2002
- 2002-07-09 AT AT02749842T patent/ATE307125T1/de not_active IP Right Cessation
- 2002-07-09 EP EP02749842A patent/EP1423373B1/en not_active Expired - Lifetime
- 2002-07-09 AU AU2002320330A patent/AU2002320330B2/en not_active Ceased
- 2002-07-09 MX MXPA04000040A patent/MXPA04000040A/es active IP Right Grant
- 2002-07-09 DE DE60206782T patent/DE60206782T2/de not_active Expired - Lifetime
- 2002-07-09 CA CA002453169A patent/CA2453169A1/en not_active Abandoned
- 2002-07-09 IL IL15973502A patent/IL159735A0/xx unknown
- 2002-07-09 WO PCT/US2002/021525 patent/WO2003006444A2/en active IP Right Grant
- 2002-07-09 ES ES02749842T patent/ES2247357T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1423373A2 (en) | 2004-06-02 |
DE60206782D1 (de) | 2006-03-02 |
AU2002320330B2 (en) | 2007-06-14 |
ATE307125T1 (de) | 2005-11-15 |
ES2247357T3 (es) | 2006-03-01 |
WO2003006444A2 (en) | 2003-01-23 |
EP1423373B1 (en) | 2005-10-19 |
DE60206782T2 (de) | 2006-07-13 |
WO2003006444A3 (en) | 2004-03-11 |
MXPA04000040A (es) | 2004-05-21 |
CA2453169A1 (en) | 2003-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0124933D0 (en) | Chemical compounds | |
RS92004A (xx) | Pirolo-triazin anilinska jedinjenja, korisna kao inhibitori kinaze | |
WO2003050087A3 (en) | Novel herbicides | |
WO2004002981A3 (en) | Herbicidal thienylalkynes | |
MXPA04001685A (es) | Derivados de sulfonilamino empleados como herbicida. | |
JO2311B1 (en) | Alkyl inhibitors Ariel phosphodiesterase-4 | |
WO2004031401A3 (en) | Novel tyrosine kinases inhibitors | |
MX2009007050A (es) | Compuestos de carboxamida y su uso como inhibidores de calpaina. | |
UA93351C2 (xx) | Похідні фталазіну як інгібітори parp$производные фталазина kak ингибиторы parp | |
RS53428B (en) | COMPOSITIONS AND ANTI-VIRUS ACTIVITY OF SUBSTITUTED AZAINDOLOXOSCETER PIPERAZINE DERIVATIVES | |
IL165262A (en) | Kinase inhibitors and pharmaceutical compositions containing them | |
TW200518740A (en) | Novel peptidomimetic NS3-serine protease inhibitors of hepatitis C virus | |
TW200642689A (en) | Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient | |
ATE402149T1 (de) | Heterozyklische substituierte amide, deren herstellung und anwendung | |
WO2004063151A3 (en) | Novel tyrosine kinase inhibitors | |
MXPA03009750A (es) | Compuestos quimicos. | |
WO2003047520A3 (en) | SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS | |
MXPA03008215A (es) | Inhibidores de integrina alfa v beta 6. | |
WO2002085906A3 (en) | Phthalazinones derivatives useful as pde4/7 inhibitors | |
MXPA05010521A (es) | Inhibidores de cinasa de amida de bifenilcarboxilica p38. | |
DK1578740T3 (da) | 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet | |
WO2003053971A8 (en) | Pyridoquinoxaline antivirals | |
RS20060072A (xx) | Derivati aminokvinolina i njihova upotreba kao veznika a3 adenozina | |
SG151288A1 (en) | 3-cyano-quinoline derivatives with antiproliferative activity | |
CA2412596A1 (en) | Cyclic gmp-specific phosphodiesterase inhibitors |